12
Participants
Start Date
December 27, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
March 30, 2028
Inaticabtagene Autoleucel Injection
"The dose was incremented according to the 3+3 principle, and the three dose levels A, B and C were given in sequence at one time, which were respectively:~A-1 dose group: 0.25×10\^6 CAR-T live cells /kg body weight~Group A (initial dose) : 0.5×10\^6 CAR-T live cells /kg body weight~Group B: 1.0×10\^6 CAR-T live cells /kg body weight~Group C: 1.5×10\^6 CAR-T live cells /kg body weight"
Lead Sponsor
Juventas Cell Therapy Ltd.
INDUSTRY